Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer

Published:2012-05-26 Issue:4 Volume:18 Page:735-742
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Sasaki Tetsuya,Fujita Ken-ichi,Sunakawa Yu,Ishida Hiroo,Yamashita Keishi,Miwa Keisuke,Saji Shigehira,Kato Yasuhisa,Sasaki Yasutsuna

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-012-0425-5.pdf

Reference22 articles.

1. Beijnen JH, Schellens JH (2004) Drug interactions in oncology. Lancet Oncol 5:489–496

2. Blower P, de Wit R, Goodin S et al (2005) Drug–drug interactions in oncology: why are they important and can they be minimized? Crit Rev Oncol Hematol 55:117–142

3. Chan A, Yap KY, Koh D et al (2011) Electronic database to detect drug–drug interactions between antidepressants and oral anticancer drugs from a cancer center in Singapore: implications to clinicians. Pharmacoepidemiol Drug Saf 20:939–947

4. Jansman FG, Idzinga FS, Smit WM et al (2005) Classification and occurrence of clinically significant drug interactions with irinotecan and oxaliplatin in patients with metastatic colorectal cancer. Clin Ther 27:327–335

5. Jansman FG, Reyners AK, van Roon EN et al (2011) Consensus-based evaluation of clinical significance and management of anticancer drug interactions. Clin Ther 33:305–314

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing polypharmacy in older adults with cancer: A pilot cluster-randomized trial protocol;Journal of Geriatric Oncology;2024-03

2. Deprescribing: A Prime Opportunity to Optimize Care of Cancer Patients;Current Oncology;2023-11-02

3. Association of polypharmacy and potential drug‐drug interactions with adverse treatment outcomes in older adults with advanced cancer;Cancer;2023-01-24

4. Clustering Diseases in Cancer and Health Organization: What Is the Gold-Standard Approach?;BioMed;2022-07-21

5. Drug‐Drug Interactions and Disease Status Are Associated With Irinotecan‐Induced Hepatotoxicity: A Cross‐Sectional Study in Shanghai;The Journal of Clinical Pharmacology;2022-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3